---
schema_version: "secwatch.filing_event.v1"
accession: "0000012208-23-000009"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T16:52:49.362971+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Bio-Rad to present at J.P. Morgan Healthcare Conference on Jan 10, 2023

## Summary
- President & CEO Norman Schwartz to present company overview at 4:30 p.m. PT.
- Q&A session with EVP/COO Andrew Last and EVP/CFO Ilan Daskal.
- Webcast link available on investor relations section of bio-rad.com.
- No specific financial results or material disclosures provided in the filing.

## SEC filing metadata
- accession: 0000012208-23-000009
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220823000009/0000012208-23-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220823000009/bio-20230110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000012208-23-000009
- JSON: https://secwatch.observer/filing/0000012208-23-000009.json
- Plain text: https://secwatch.observer/filing/0000012208-23-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.